Patented Medicine Prices Review Board 2023–24 Departmental Results Report

The Patented Medicine Prices Review Board Canada's 2023–24 Departmental Results Report measures the department's performance against its stated plans and priorities. The report is available in HTML format and was last updated on 2026-04-16. It is published under the OGL-CA-2.0 license.

Use Cases

• Analyze government agency performance based on reported departmental results.
• Benchmark regulatory outcomes against stated plans and priorities.
• Study pharmaceutical pricing policy and oversight mechanisms in Canada.

Strengths

• Report is published by the official Patented Medicine Prices Review Board Canada.
• Data is licensed under the open OGL-CA-2.0 license.
• Last update timestamp is precisely recorded as 2026-04-16 19:27:00.655892.

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Patented Medicine Prices Review Board Canada | Conseil d'examen du prix des médicaments brevetés Canada

Time Range

2023–24

Freshness

Last updated 2026-04-16 19:27:00.655892; freshness should be verified.

Geography

Canada